Viewing StudyNCT04221542

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 2:08 PM
Last Modification Date: 2024-10-26 @ 1:25 PM
Study NCT ID: NCT04221542
Status: RECRUITING
Last Update Posted: 2024-06-13
First Post: 2019-12-16
Brief Title: Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
Organization: Amgen
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
XmAb View
AMG 509 View
mCRPC View
Metastatic Castration-resistant Prostate Cancer View
Prostate cancer View
PSMA View
STEAP1 View
STEAP1 targeted therapy View
Solid tumor View
Immunotherapy View
Immuno-oncology View
Immunooncology View
Bispecific T-Cell engager View
BiTE View